ICH Guidance Will Clarify Integrated Safety, Efficacy Summary Submissions
This article was originally published in The Tan Sheet
Executive Summary
FDA plans to issue a guidance clarifying what firms should include in integrated summaries of safety and efficacy in common technical document submissions
You may also be interested in...
CTD Submission Voluntary But Recommended, Guidance Says
Common technical document submission will remain voluntary but recommended, according to an August FDA draft guidance entitled "Submitting Marketing Applications According to the ICH-CTD Format - General Considerations."
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands